Total Infliximab ELISA Assay


The Total Infliximab ELISA Assay Kit is an Enzyme immunoassay for the semi-quantitative determination of total (free and drug-bound) antibodies to Infliximab (ATI) in serum and plasma samples. The Total Infliximab (Remicade®) ELISA Assay Kit is for Research Use Only and is not for use in diagnostics procedures.

Total Infliximab ELISA Assay

Total Infliximab ELISA Assay is for research use only

Size: 1 x 96 wells
Sensitivity: 10 tAU/mL
Dynamic Range: Cut-off Control
Incubation Time:  1.5 hours
Sample Type:  Serum, Plasma
Sample Size: 10 µL
Alternative Names: Total Antibodies to Infliximab ELISA, Total Antibodies to Infliximab (Remicade) ELISA, Total Remicade ELISA

Assay Background

The drug Infliximab (trade name Remicade® and Remsima®) is a chimeric monoclonal antibody and used to treat auto-immune disorders. One of the major concerns, despite of its wide usage, is the potential development of anti-Infliximab antibodies (ATI) which in turn may interfere with the drug efficacy as mainly judged by observing the relapse of signs and symptoms of disease and necessitate dose-escalation or potentially ending up the treatment.

The ImmunoGuide Total Antibody to Infliximab ELISA Kit can be efficiently used for measuring free and Infliximab-bound antibodies against the drug Infliximab. In combination with the drug level determination, the Total Antibody to Infliximab ELISA Kit has been designed for the measurement of free antibodies against this drug. It also detects such antibodies which already are bound to the drug, even if the drug is present in a 20 fold excess.

The kit is shipped at ambient temperature and should be stored at 2-8°C. Keep away from heat or direct sun light. The storage and stability of specimen and prepared reagents is stated in the corresponding chapters. The microtiter strips are stable up to the expiry date of the kit in the broken, but tightly closed bag when stored at 2–8°C.

Anti-Infliximab (Remicade) ELISA Assay Kit
Infliximab (Remicade) ELISA Assay Kit
Infliximab ELISA mAb-based Assay

Additional Information

Assay Principle

The Eagle Biosciences Total Antibody to Infliximab ELISA Assay Kit serves for the determination of total antibodies (free and Infliximab-bound) against Infliximab in serum and plasma samples. During sample preparation, the Infliximab-bound anti-Infliximab antibodies are dissociated from the complex in order to acquire free anti-Infliximab antibodies. During the incubation period, antibodies to Infliximab (ATI) are replaced and bridged in the well with its Fab arms, between the Infliximab coated on the well and the conjugate Infliximab labelled with peroxidase. After washing away the components the bound enzymatic activity is detected by addition of tetramethylbenzidine (TMB) chromogen-substrate. Finally, the reaction is terminated with stop solution. The positive reaction is related with the presence of ATI in the sample.

Assay Procedure

  1. Pipette 100 µL of Assay Buffer into each of the wells to be used.
  2. Pipette 50 µL of Enzyme Conjugate (HRP-Infliximab) into each well.
  3. Pipette 40 µL of dissociation buffer-mixed (as described in section 10.2) Negative Control, Positive Control and Samples into the respective wells of the microtiter ELISA plate.
  4. Cover the plate with adhesive seal. Shake plate carefully. Incubate 60 min at room temperature (RT) (20-25°C).
  5. Remove adhesive seal. Aspirate or decant the incubation solution. Wash the plate 3 X 300 μL of Diluted Wash Buffer per well. Remove excess solution by tapping the inverted plate on a paper towel.
  6. Pipette 100 µL of Ready-to-Use TMB Substrate Solution into each well.
  7. Incubate 15 min at RT. Avoid exposure to direct sunlight.
  8. Stop the substrate reaction by adding 100 µL of Stop Solution into each well. Briefly mix contents by gently shaking the plate. Color changes from blue to yellow.
  9. Measure optical density (OD) with a photometer at 450 nm (Reference at OD620 nm is optional) within 15 min after pipetting the Stop Solution.


Product Manual


Please note: All documents above are for reference use only and should not be used in place of the documents included with this physical product. If digital copies are needed, please contact us.

Product Citations